< Back to previous page
Phloretin in treatment of neuroinflammatory and demyelinating diseases: further insights in possible nutraceutical vs pharmaceutical market approach (R-11397)
UHasselt and PC Fruit have filed a provisional patent application on the use of fruit components for the treatment of neurodegenerative diseases, like multiple sclerosis (MS). In this project, a third party will be consulted to perform a thorough analysis of the market potential of this product in the nutraceutical and pharmaceutical market. IP strategy and licence roadmaps for both fields are evaluated.
Date:1 Dec 2020 → 30 Nov 2021
Keywords:flavonoids, Multiple Sclerosis, Neurodegenerative disease
Disciplines:Neurosciences not elsewhere classified